166 related articles for article (PubMed ID: 2833920)
1. Lisinopril and nifedipine: no acute interaction in normotensives.
Lees KR; Reid JL
Br J Clin Pharmacol; 1988 Mar; 25(3):307-13. PubMed ID: 2833920
[TBL] [Abstract][Full Text] [Related]
2. A clinical pharmacological study of nifedipine and lisinopril alone and in combination.
Lees KR; Meredith PA; Reid JL
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S105-7. PubMed ID: 2455105
[TBL] [Abstract][Full Text] [Related]
3. Different hemodynamic (24-h ambulatory blood pressure monitoring) and renin-inhibiting effect of a 1-week treatment with enalapril and lisinopril.
Cocco G; Hari J
Clin Cardiol; 1991 Nov; 14(11):881-4. PubMed ID: 1662562
[TBL] [Abstract][Full Text] [Related]
4. Comparative pharmacokinetics and pharmacodynamics of lisinopril and enalapril, alone and in combination with propranolol.
Bendtsen F; Henriksen JH
J Hum Hypertens; 1989 Jun; 3 Suppl 1():139-45. PubMed ID: 2550636
[TBL] [Abstract][Full Text] [Related]
5. A comparison of single doses of lisinopril and enalapril in hypertension.
Dews I; Wiseman WT; al-Khawaja I; Stephens J; VandenBurg M
J Hum Hypertens; 1989 Jun; 3 Suppl 1():35-9. PubMed ID: 2550644
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of enalapril and lisinopril in subjects with normal and impaired hepatic function.
Hayes PC; Plevris JN; Bouchier IA
J Hum Hypertens; 1989 Jun; 3 Suppl 1():153-8. PubMed ID: 2550638
[TBL] [Abstract][Full Text] [Related]
7. Increase in vasoactive intestinal polypeptides (VIP) by the angiotensin converting enzyme (ACE) inhibitor lisinopril in congestive heart failure. Relation to haemodynamic and hormonal changes.
Woie L; Dickstein K; Kaada B
Gen Pharmacol; 1987; 18(6):577-87. PubMed ID: 2822521
[TBL] [Abstract][Full Text] [Related]
8. Acute hemodynamic and hormonal effects of lisinopril (MK-521) in congestive heart failure.
Dickstein K; Aarsland T; Woie L; Abrahamsen AM; Fyhrquist F; Cummings S; Gomex HJ; Hagen E; Kristianson K
Am Heart J; 1986 Jul; 112(1):121-9. PubMed ID: 3014850
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic, hormonal, and pharmacokinetic aspects of treatment with lisinopril in congestive heart failure.
Dickstein K
J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S73-81. PubMed ID: 2442558
[TBL] [Abstract][Full Text] [Related]
10. Unmasking of the hypotensive effect of nifedipine in normotensives by addition of the angiotensin converting enzyme inhibitor benazepril.
Jakobsen J; Glaus L; Graf P; Degen P; Maurice NP; Bellet M; Ménard J
J Hypertens; 1992 Sep; 10(9):1045-51. PubMed ID: 1328364
[TBL] [Abstract][Full Text] [Related]
11. Onset of action of captopril, enalapril, enalaprilic acid and lisinopril in normal man.
Semple PF; Cumming AM; Meredith PA; Morton JJ
Cardiovasc Drugs Ther; 1987; 1(1):45-50. PubMed ID: 2856460
[TBL] [Abstract][Full Text] [Related]
12. Effects on plasma angiotensin-converting enzyme activity and circulating renin of lisinopril and enalapril alone and in combination with propranolol in healthy volunteers.
Hansen EF; Bendtsen F; Henriksen JH
Pharmacol Toxicol; 1999 Mar; 84(3):110-4. PubMed ID: 10193670
[TBL] [Abstract][Full Text] [Related]
13. The clinical pharmacology of lisinopril.
Case DE
J Hum Hypertens; 1989 Jun; 3 Suppl 1():127-31. PubMed ID: 2550635
[TBL] [Abstract][Full Text] [Related]
14. Comparative pharmacokinetics of enalapril and lisinopril, alone and with hydralazine.
McLean AJ; Drummer OH; Smith HJ; Froomes P; McNeil JJ
J Hum Hypertens; 1989 Jun; 3 Suppl 1():147-51. PubMed ID: 2550637
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic responses to converting enzyme inhibition in patients with renal disease.
August P; Cody RJ; Sealey JE; Laragh JH
Am J Hypertens; 1989 Aug; 2(8):599-603. PubMed ID: 2550029
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and dynamic interactions of the angiotensin-converting enzyme inhibitor imidapril with hydrochlorothiazide, bisoprolol and nilvadipine.
Breithaupt-Grögler K; Ungethüm W; Meurer-Witt B; Belz GG
Eur J Clin Pharmacol; 2001 Jul; 57(4):275-84. PubMed ID: 11549204
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of lisinopril and nifedipine retard in essential hypertension: a double-blind, placebo-controlled trial.
Richardson PJ; Meany TB; Johnston GD; Kondowe G; Grimmer SF; Breckenridge AM
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S96-8. PubMed ID: 2455154
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of lisinopril.
Beermann B
Am J Med; 1988 Sep; 85(3B):25-30. PubMed ID: 2844083
[TBL] [Abstract][Full Text] [Related]
19. Comparative trial of lisinopril and nifedipine in mild to severe essential hypertension.
Mörlin C; Baglivo H; Boeijinga JK; Breckenridge AM; Clement D; Johnston GD; Klein W; Kramer R; Luccioni R; Meurer KA
J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S49-52. PubMed ID: 2442552
[TBL] [Abstract][Full Text] [Related]
20. Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.
Lancaster SG; Todd PA
Drugs; 1988 Jun; 35(6):646-69. PubMed ID: 2844497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]